You are in: eMedicine Specialties > Pediatrics > Critical Care
|
Acidosis, Metabolic Last Updated: August 17, 2006 |
|
| Synonyms and related keywords: metabolic acidosis, bicarbonate, anions, cations, hydrogen, anion gap, anion gap acidosis, normal anion gap metabolic acidosis, renal tubular acidosis, RTA, acid-base disorder, plasma bicarbonate, plasma bicarbonate level, acidemia
|
|   |
AUTHOR INFORMATION
| Section 1 of 10  |
|
| Author: Margaret A Priestley, MD, Assistant Professor of Anesthesia and Pediatrics, University of Pennsylvania; Associate Director of Trauma, Department of Anesthesiology and Critical Care Medicine, The Children's Hospital of Philadelphia |
| Margaret A Priestley, MD, is a member of the following medical societies:
American Academy of Pediatrics,
American Medical Association, and
Society of Critical Care Medicine |
| Editor(s): G Patricia Cantwell, MD, Associate Clinical Professor, Department of Pediatrics, Miller School of Medicine, University of Miami; Director of Pediatric Critical Care Medicine, Jackson Children's Hospital; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc;
Barry Evans, MD, Assistant Professor of Pediatrics, Temple University Medical School, Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center;
Mary E Cataletto, MD, Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Associate Professor, Department of Clinical Pediatrics, State University of New York at Stony Brook;
and Maureen Strafford, MD, Arnold P Gold Foundation Associate Professor, Departments of Anesthesiology and Pediatrics, Tufts University and Tufts-New England Medical Center |
Disclosure
|   |
INTRODUCTION
| Section 2 of 10  |
|
Background: A metabolic acidosis is an acid-base disorder characterized by a decrease in serum pH that results from either a primary decrease in plasma bicarbonate concentration ([HCO3-]) or an increase in hydrogen ion concentration ([H+]). It is not a disease but rather a biochemical abnormality. The clinical manifestations of a metabolic acidosis are nonspecific, and its differential diagnoses include common and rare diseases. Pathophysiology: A primary metabolic acidosis is a pathophysiologic state characterized by an arterial pH less than 7.35 in the absence of an elevated PaCO2. It is created by one of three mechanisms: (1) increased production of acids, (2) decreased excretion of acids, or (3) loss of alkali.
Acutely, medullary chemoreceptors compensate for a metabolic acidosis through increases in alveolar ventilation. The resulting tachypnea and hyperpnea reduces the PaCO2 in an attempt to increase the pH back toward normal. In a primary metabolic acidosis, the degree of acute respiratory compensation can be predicted by the following relationship:
Expected PaCO2 = (1.5 X [HCO3-]) + 8 ± 2
If the measured PaCO2 is higher than the expected PaCO2, a concomitant respiratory acidosis is also present. The development of normocapnia or hypercapnia when a severe metabolic acidosis exists often signals respiratory muscle fatigue, impending respiratory failure, and the possible need for initiating mechanical ventilation.
The kidneys are responsible for reclaiming filtered bicarbonate (HCO3-) and eliminating the daily acid load generated from nitrogen (protein) metabolism. Normally, the kidneys excrete hydrogen ions (H+) through the formation of titratable acids and ammonium. The ability of the kidney to excrete an increased acid load generally begins 12-24 hours after the compensatory hyperventilation begins and continues for 1-3 days. Over time, the kidneys attempt to increase reabsorption of HCO3- to compensate for the acidosis. The severity of the acidosis depends on the rapidity of bicarbonate loss and the ability of the kidney to replenish bicarbonate.
Anion gap
To achieve electrochemical balance, ionic elements in the extracellular fluid must equal a net charge of zero. Therefore, the number of negatively charged ions (anions) should equal the number of positively charged ions (cations). Measured serum anions are chloride and bicarbonate, and the unmeasured anions include phosphates, sulfates, and proteins (eg, albumin). The primary measured serum cation is sodium, but other cations exist, such as calcium, potassium, and magnesium. Under typical conditions, unmeasured anions exceed unmeasured cations; this is referred to as the anion gap and can be represented by the following formulas:
(Chloride + Bicarbonate) + Unmeasured Anions =
Sodium + Unmeasured Cations
Unmeasured Anions – Unmeasured Cations = Sodium – (Chloride + Bicarbonate)
Anion Gap = (Sodium) – (Chloride + Bicarbonate)
Practically, a metabolic acidosis is divided into processes that are associated with a normal anion gap (8-12 mEq/L) or an elevated anion gap (>12 mEq/L). A normal anion gap metabolic acidosis involves no gain of unmeasured anions; however, because of the need for electrical neutrality, serum chloride replaces the depleted bicarbonate, and hyperchloremia develops. In contrast, an elevated anion gap metabolic acidosis is caused when extra unmeasured anions are added to the blood.
General physiologic and metabolic effects
The clinical manifestations of a metabolic acidosis are related to the degree of acidemia. Initially, patients with a metabolic acidosis develop a compensatory tachypnea and hyperpnea; if the acidemia is severe, the child can present with significant work of breathing and distress. An increase in serum hydrogen ion concentration results in pulmonary vasoconstriction, which raises pulmonary artery pressure and pulmonary vascular resistance. An increase in right ventricular afterload and, potentially, right ventricular dysfunction can then occur. This is especially problematic in newborn infants with persistent pulmonary hypertension. Tachycardia is the most common cardiovascular effect seen with a mild metabolic acidosis. As the serum pH continues to fall below 7.2, myocardial depression occurs because hydrogen ions act as a negative inotrope and peripheral vasodilation occurs. Also, with acidemia, cardiovascular response to endogenous and exogenous catecholamines can decrease, which can possibly
exacerbate
hypotension in children with volume depletion or shock.
Central nervous system manifestations can include headache, lethargy, confusion, or any change in mental status secondary to a decrease in intracerebral pH. Cerebral vasodilation occurs as a result of a metabolic acidosis and may contribute to an increase in intracranial pressure.
During a metabolic acidosis, excess hydrogen ions move toward the intracellular compartment and potassium moves out of the cell into the extracellular space (serum). For every decrease in the serum pH by 0.1, a concomitant increase in the serum potassium level by 0.5 mEq occurs. As a result, hyperkalemic arrhythmias (peaked T waves and QRS widening) and ventricular fibrillation may occur. Other acute metabolic effects of acidemia include insulin resistance, increased protein degradation, and reduced adenosine triphosphate (ATP) synthesis. During acidemia, the oxyhemoglobin dissociation curve shifts to the right; oxygen has a lower affinity for hemoglobin, but hemoglobin releases oxygen more readily. Also, nonspecific gastrointestinal complaints, such as abdominal pain, nausea, or vomiting, may be present. Frequency:
- In the US: Metabolic acidosis is a biochemical derangement occurring as part of certain disease states and conditions. No statistics are available on its frequency.
Mortality/Morbidity: The underlying disorder usually produces most of the signs and symptoms in children with a mild or moderate metabolic acidosis. Untreated severe metabolic acidosis may be associated with life-threatening arrhythmias, myocardial depression, and respiratory muscle fatigue but is not the ultimate cause of morbidity and mortality.
Race: No racial predilection exists.
Sex: The prevalence rates of metabolic acidosis are equal for males and females.
Age: Metabolic acidosis can occur in any age group.
|   |
CLINICAL
| Section 3 of 10  |
|
History: The etiology of a metabolic acidosis is often apparent from the history and physical examination. The following questions are included in a complete investigation of the patient's history: - Is there a prodrome of anorexia, nausea, vomiting, or diarrhea? In pediatric patients, diarrhea is the most common cause of a metabolic acidosis.
- Is the metabolic acidosis associated with seizures, a depressed sensorium, or both in a neonate? This warrants consideration of an inborn error of metabolism.
- Is there a history of depressed mental status, lethargy, and poor feeding in an infant? Left-sided obstructive cardiac lesions should be considered (eg, aortic coarctation or hypoplastic left heart syndrome).
- Is there failure to thrive to suggest a chronic metabolic acidosis? This can be seen with renal insufficiency or renal tubular acidosis (RTA).
- Is there new onset of polyuria, polydipsia, and weight loss? This could signify undiagnosed diabetes mellitus and diabetic ketoacidosis in a child.
- Is there a possible ingestion of a toxin or other form of intoxication? What medications are in the home? Suspect a poisoning in a healthy child who quickly develops a metabolic acidosis; possible agents are ethanol, ethylene glycol, salicylates, and methanol.
- Is there a history of trauma, hives, or fever? Consider states associated with a lactic acidosis secondary to shock from hypovolemia, sepsis, cardiac failure, anaphylaxis, or spinal shock.
- Is there a chronic medical or surgical issue? Examples to be concerned with are chronic renal failure, presence of a ureterosigmoidostomy, or diabetes mellitus.
Physical: Clinical findings generally depend on the etiology and severity of the metabolic acidosis. - Hyperventilation or Kussmaul breathing may often be the first sign of a metabolic acidosis in a child.
- CNS manifestations may include lethargy, coma, and seizures.
- Signs of dehydration may be tachycardia, dry mucous membranes, and delayed capillary refill.
- Signs of a low cardiac output state may be weak pulses or cardiac gallop; an associated cardiovascular abnormality (eg, cardiomyopathy or left-sided cardiac lesion) may exist.
Causes: The causes of a metabolic acidosis can be classified on the basis of a normal or elevated anion gap. - An elevated anion gap is created by inorganic (eg, phosphate or sulfate), organic (eg, ketoacids or lactate), or exogenous (eg, salicylate) acids incompletely neutralized by bicarbonate. Frequent causes of an elevated anion gap metabolic acidosis is represented by the mnemonic MUDPILES:
- Methanol
- Uremia
- Diabetic ketoacidosis
- Paraldehyde
- Iron, isoniazid (INH)
- Lactic acid
- Ethanol, ethylene glycol
- Salicylates
- A normal anion gap metabolic acidosis occurs when loss of bicarbonate from the GI tract or kidneys is excessive or when hydrogen ions cannot be secreted because of renal failure. The causes can be represented by the mnemonic USEDCARP:
- Ureterostomy
- Small bowel fistula
- Extra chloride
- Diarrhea
- Carbonic anhydrase inhibitors (eg, acetazolamide)
- Adrenal insufficiency
- Renal tubular acidosis
- Pancreatic fistula
- Infants are more likely to develop a normal anion gap metabolic acidosis secondary to significant losses of bicarbonate in diarrheal stools. The stool output can contain as much as 70-80 mEq/L of bicarbonate.
- Patients with a ureterosigmoidostomy may lose bicarbonate in exchange for the reabsorption of chloride and ammonium as urine accumulates in the sigmoid colon.
- Children with congenital or acquired renal tubular acidosis can lose large amounts of bicarbonate, with or without concomitant potassium loss.
- Inborn errors of metabolism may result in a metabolic acidosis, with or without hypoglycemia or hyperammonemia.
- In children, metabolic acidosis is frequently caused by lactate. Lactate is the end product of anaerobic glycolysis, which can be represented by the following equation:
Glucose + 2 ATP + 2 H2PO4 ® 2 Lactate + 2 ADP + 2 H2O
- Hydrogen ions generated by the hydrolysis of ATP converts lactate to lactic acid.
- Under normal conditions, the liver rapidly converts these small amounts of lactic acid to pyruvic acid, which is then metabolized to carbon dioxide and water.
- Under conditions of oxygen deprivation and decreased oxygen delivery to the tissues, anaerobic metabolism produces excessive amounts of lactic acid. Most disease processes that result in decreased oxygen delivery also frequently lead to diminished hepatic function, further compounding lactic acid accumulation.
- Conditions that frequently lead to lactic acidosis include shock, sepsis, thiamine deficiency, diabetic ketoacidosis, and cellular poisoning (eg, cyanide toxicity).
|   |
DIFFERENTIALS
| Section 4 of 10  |
|
Adrenal Insufficiency Anemia, Acute Bacteremia Cardiomyopathy, Dilated Chronic Kidney Disease Coarctation of the Aorta Dehydration Diabetic Ketoacidosis Diarrhea
Hyperammonemia Hypoplastic Left Heart Syndrome Interrupted Aortic Arch Intestinal Volvulus Maple Syrup Urine Disease Meningococcal Infections Myocarditis, Nonviral Myocarditis, Viral Necrotizing Enterocolitis
Neonatal Sepsis Neuroleptic Malignant Syndrome Ornithine Transcarbamylase Deficiency Phenylketonuria Pneumococcal Bacteremia Sepsis Toxic Shock Syndrome Toxicity, Ethanol Toxicity, Iron
Toxicity, Isoniazid Toxicity, Salicylate
Other Problems to be Considered:
Renal tubular acidosis
Lactic acidosis
Cyanide toxicity
Ethylene glycol toxicity
Methanol toxicity |
|
Patient Education
|
|
Click here for patient education.
|
|
|
|
|
|   |
WORKUP
| Section 5 of 10  |
|
Lab Studies:
- An arterial blood gas measurement reveals the acidemia. In addition, it shows the degree of respiratory compensation. To determine whether respiratory compensation is adequate or a mixed metabolic and respiratory acidosis exists, the Winter formula can be applied:
Expected PaCO2 = (1.5 X [HCO3-]) + 8 ± 2
- A PaCO2 that is significantly higher than the level indicated by the Winter formula indicates that the patient is unable to compensate appropriately. This condition may be caused by a depressed mental state, airway obstruction, or fatigue. The inability to compensate may be especially important in patients with diabetic ketoacidosis who are at risk for cerebral edema.
- Basic laboratory tests for a child with a metabolic acidosis should include measurements of electrolytes, blood urea nitrogen (BUN), creatinine, and serum glucose, as well as a urinalysis.
- Calculate the anion gap from the electrolyte levels. This guides the initial diagnostic approach (ie, for a normal or elevated anion gap).
- The serum potassium level is often abnormal. Patients with a metabolic acidosis may have a low serum potassium level due to excessive body losses of potassium or an elevated serum potassium level secondary to renal insufficiency, tissue breakdown, and shift of potassium from the intracellular space to the extracellular space as a result of acidemia.
- Patients with renal insufficiency have elevated BUN and creatinine levels. A BUN-to-creatinine ratio greater than 20:1 supports the diagnosis of prerenal azotemia and hypovolemia.
- Hypoglycemia associated with a metabolic acidosis can be caused by adrenal insufficiency or liver failure.
- Hyperglycemia, glycosuria, ketonuria, and a metabolic acidosis support the diagnosis of diabetic ketoacidosis. Less commonly, this combination of findings can be secondary to an inborn error of metabolism.
- Normoglycemia, glycosuria, and a metabolic acidosis can occur in children with type II renal tubular acidosis (Fanconi syndrome).
- Starvation causes ketosis, but a metabolic acidosis may be absent or mild (bicarbonate level >18).
- The serum lactate level can be monitored as an adjunct to evaluate the response to therapy.
- The osmole gap may be helpful in diagnosing a suspected ingestion of a toxic substance. An elevated osmole gap (>20 mOsm/L) with a metabolic acidosis can suggest the presence of osmotically active agents such as methanol, ethylene glycol, or ethanol.
- Osmole Gap = Measured Serum Osmolality – Estimated Serum
Osmolality
- Estimated Serum Osmolality = 2(Na+) + [Glucose /18] + [BUN /2.8]
- Normal serum osmolality is 280-295 mOsm/L
- Hypoalbuminemia is the most common cause of a low anion gap. Albumin represents about half of the total unmeasured anion pool; for every decrease of 1 g/dL of the serum albumin level, the serum anion gap decreases by 2.5 mEq/L.
Imaging Studies:
- Echocardiography is performed if a left-sided obstructive lesion in a neonate or a new occurrence of a cardiomyopathy presenting with a lactic acidosis is suggested.
- CT scans for an infectious source or ischemic bowel should be performed, if indicated.
|   |
TREATMENT
| Section 6 of 10  |
|
Medical Care: A metabolic acidosis is a biochemical derangement resulting from one of many different disease processes; therefore, the key to successful treatment lies in appropriately managing the underlying disorder. For example, insulin administration is necessary in cases of diabetic ketoacidosis, and restoration of adequate perfusion with crystalloid administration is necessary in cases of dehydration. - In instances in which the serum bicarbonate level is only mildly to moderately depressed (>10-12 mEq/L), bicarbonate replacement may not be necessary. If the underlying disease is treated appropriately, the kidneys are able to replenish bicarbonate stores within 3-4 days, unless significant renal dysfunction is present.
- In some disease states, the use of bicarbonate therapy is clearly indicated. For patients with chronic renal failure or renal tubular acidosis, bicarbonate replacement is necessary because of known ongoing bicarbonate losses. In salicylate intoxication, short-term therapy with bicarbonate to create an alkalemic environment enhances toxin elimination.
- Do not overestimate or overcorrect the bicarbonate deficit. Rapid infusion of bicarbonate and overcorrection of the metabolic acidosis can lead to complications such as tetany, seizures, and hypokalemia by worsening the preexisting hypocalcemia and hypokalemia.
- Doses of bicarbonate exceeding 1 mEq/kg per dose may lead to an alkaline overshoot. For each 0.1 increase in pH, oxygen availability may decrease by 10% because of the shift of the oxygen-hemoglobin dissociation curve to the left.
- Administered bicarbonate is dissociated into carbon dioxide and water.
- Carbon dioxide diffuses through the blood-brain barrier, whereas bicarbonate does not; this may lead to a paradoxical CNS acidosis.
- Parenteral forms of sodium bicarbonate are available as 4% (1/2 strength) or 8% solutions. The sodium load can be significant when multiple bolus doses are administered.
- If hypernatremia is a concern, consider continuous infusion of sodium bicarbonate as part of the maintenance intravenous solution. For example, 34 mEq/L of sodium bicarbonate can be added to a 0.22% sodium chloride solution to make up a 0.45% salt solution for maintenance intravenous therapy.
- Hemodialysis is another option for correcting a severe metabolic acidosis associated with renal failure or intoxication with methanol or ethylene glycol.
- Thiamine deficiency is a rare disorder in developed countries; it can occur in breastfed infants of mothers who have inadequate thiamine intake or in patients with unsupplemented total parenteral nutrition.
- Thiamine is an essential vitamin for brain development in infants. Thiamine acts as a cocarboxylase, catalyzing decarboxylation of pyruvic acid and acetyl-coenzyme A (acetyl-CoA). It also acts as a coenzyme for pyruvate dehydrogenase activity and oxidative decarboxylation of alpha-ketoglutarate to succinyl-CoA.
- Thiamine deficiency causes excess pyruvate levels and impaired fatty acid metabolism through the Krebs cycle. Generation of nicotinamide adenine dinucleotide (NADH) in the Krebs cycle is also impaired, stimulating anaerobic glycolysis and leading to increased lactate production.
- The clinical presentation of thiamine deficiency is characterized by a severe lactic acidosis and shock, which is often resistant to inotropic agents and volume resuscitation. It can produce a polyneuropathy, weakness, paralysis, cardiac failure, or a combination thereof. Lack of thiamine intake can lead to depleted stores within 10 days.
- Thiamine deficiency is a likely diagnosis for a patient on total parenteral nutrition without multivitamins for 2 or more weeks, who then develops a metabolic acidosis, lactic acidosis, and shock resistance to inotropic support. Thiamine administration rapidly corrects the clinical symptomatology.
- THAM (tromethamine; tris[hydroxymethyl]-aminomethane) is a buffer that can be used to treat acidosis when concerns exist regarding carbon dioxide accumulation from the metabolism of administered sodium bicarbonate. THAM increases serum bicarbonate predictably:
- THAM + H2CO3 ® THAM-H + HCO3
- H2CO3 ® CO2 + H2O
- Dose: 1 mEq/kg
- The use of sodium bicarbonate therapy in cases of diabetic ketoacidosis and lactic acidosis is controversial. In 2001, an article published by Glaser et al reported that patients with diabetic ketoacidosis who were treated with sodium bicarbonate were at increased risk for cerebral edema.
Surgical Care: Tissue ischemia or necrosis from bowel obstruction or necrotizing enterocolitis, with or without peritonitis, may lead to metabolic acidosis. Especially in newborns with necrotizing enterocolitis, this may be the first laboratory abnormality associated with a surgical abdomen. Consultations: Consultations depend on the underlying etiology of metabolic acidosis. - Consult with a nephrologist for children with renal failure, who may or may not require dialysis.
- Consult with a geneticist for inborn errors of metabolism.
- Consult with a surgeon if the underlying cause of metabolic acidosis is surgical in nature (necrotizing enterocolitis, malrotation, volvulus, ruptured appendicitis).
- Consult with an endocrinologist for children whose metabolic acidosis is caused by diabetic ketoacidosis.
Diet: The underlying disease state (eg, diabetes, renal failure) may require diet modification.
|   |
MEDICATION
| Section 7 of 10  |
|
Specific therapies are directed at the underlying disease process.
Drug Category: Alkalinizing agents -- Sodium bicarbonate is used as a gastric, systemic, and urinary alkalinizer and has been used in the treatment of acidosis resulting from metabolic and respiratory causes, including diabetic coma, diarrhea, kidney disturbances, and shock. Alternatively, THAM is a buffering agent that increases pH without increasing levels of PaCO2. It may be used to correct metabolic acidosis if sodium bicarbonate is contraindicated. Drug Name
| Sodium bicarbonate -- Buffering agent for metabolic acidosis when significant bicarbonate losses have occurred. |
|---|
| Adult Dose | 1-2 mEq/kg/dose IV |
|---|
| Pediatric Dose | Bicarbonate deficit = (Desired bicarbonate – measured bicarbonate) X weight (kg) X 0.6 Replace only one half of total deficit initially over several hours, then reassess
Dosage range: 0.5-1 mEq/kg/dose IV| Contraindications | Alkalosis; hypernatremia; hypocalcemia; severe pulmonary edema; unknown abdominal pain |
|---|
| Interactions | Urinary alkalinization induced by increased sodium bicarbonate concentrations may cause decreased levels of lithium, tetracyclines, chlorpropamide, methotrexate, and salicylates; may cause increased levels of amphetamines, pseudoephedrine, flecainide, anorexiants, mecamylamine, ephedrine, quinidine, and quinine |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Only used to treat documented metabolic acidosis and hyperkalemia-induced cardiac arrest; can cause alkalosis, decreased plasma potassium level, hypocalcemia, and hypernatremia; caution in electrolyte imbalances such as CHF, cirrhosis, edema, corticosteroid use, or renal failure; when administering, avoid extravasation because tissue necrosis can result |
|---|
|
|---|
Drug Name
| Tromethamine (THAM) -- Also called tris(hydroxymethyl)-aminomethane. Combines with hydrogen ions to form bicarbonate buffer. Used to prevent and correct systemic acidosis. Available as 0.3-mol/L IV solution containing 18 g (150 mEq) per 500 mL (0.3 mEq/mL). |
|---|
| Adult Dose | Not established |
|---|
| Pediatric Dose | 0.5-1 mEq/kg/dose IV (ie, 1.66-3.33 mL/kg/dose)
Alternatively, may calculate dose with the following formula:
mL of 0.3 mol/L tromethamine = body weight (kg) X base deficit (mEq/L) X 1.1 (factor of 1.1 accounts for about a 10% reduction in buffering capacity due to presence of sufficient acetic acid to lower pH of the 0.3-mol/L solution to approximately 8.6)
Typical initial dose: 3-16 mL/kg/h IV; titrate according to serum pH| Contraindications | Documented hypersensitivity; renal failure; uremia |
|---|
| Interactions | None reported |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | May induce respiratory depression and hypoglycemia, which may require ventilatory assistance and administration of glucose; reduce dose in renal impairment; monitor serum and urine pH. |
|---|
|
|---|
Drug Category: Vitamins -- Thiamine deficiency is a rare disorder in developed countries; it can occur in breastfed infants of mothers who have inadequate thiamine intake or in patients with unsupplemented total parenteral nutrition.Drug Name
| Thiamine hydrochloride (Thiamilate) -- Essential coenzyme that combines with ATP to form thiamine pyrophosphate. Dosage forms include a parenteral injection (l00 mg/mL) and tabs. |
|---|
| Adult Dose | 5-30 mg IV/IM tid for 2 wk, followed by 5-30 mg/d PO qd or divided tid for 1 mo
Wernicke syndrome: 100 mg IV for 1 dose, then 50-100 mg/d IV/IM until patient resumes normal diet| Pediatric Dose | 10-25 mg/dose IV/IM qd (if critically ill) or 10-50 mg PO qd for 2 wk, then 5-10 mg/dose PO qd for 1 mo |
|---|
| Contraindications | Documented hypersensitivity |
|---|
| Interactions | Neuromuscular agents may enhance effects of thiamine; high-carbohydrate diets or IV dextrose solutions may increase thiamine requirements; large doses may interfere with serum theophylline assay. |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Pregnancy category A if <1.4 mg/d (RDA), pregnancy category C if >1.4 mg/d; avoid PO dosing in patients with GI disorders that prevent absorption; administer before beginning a glucose infusion; sensitivity reactions can occur (intradermal test-dose recommended in suspected sensitivity); deaths have resulted from IV use; rash, angioedema, warmth, and tingling may occur |
|---|
|
|---|
|   |
FOLLOW-UP
| Section 8 of 10  |
|
Further Inpatient Care:
- The priority is to determine the underlying etiology that causes the metabolic acidosis; the metabolic acidosis is a symptom rather than a disease.
- Further inpatient management, including critical care, depends upon the underlying etiology. Children with inherited metabolic abnormalities, poisoning, or renal failure may require hemodialysis. Children with lactic acidosis caused by circulatory failure, thiamine deficiency, or septic shock require inotropic support, antibiotics, and appropriate supportive care. Children with diabetic ketoacidosis must be treated with insulin.
Transfer:
- Transfer patients to an ICU or pediatric hospital depending on the nature of the disease that led to metabolic acidosis and the need for subspecialty care.
Complications:
- Untreated, severe metabolic acidosis can lead to myocardial depression, seizures, shock, and multiorgan failure.
- Bicarbonate administration during treatment for diabetic ketoacidosis has been associated with an increased risk of cerebral edema.
Prognosis:
- Patient outcome depends on the nature of the disease process that led to metabolic acidosis. Children with an inherited metabolic disease require long-term specialized management and a special diet. Those with diabetic ketoacidosis need lifelong insulin administration and an appropriate diet. Those who develop a metabolic acidosis secondary to a toxic ingestion or poisoning have the potential to recover without long-standing consequences.
|   |
MISCELLANEOUS
| Section 9 of 10  |
|
Medical/Legal Pitfalls:
- Inability to recognize the etiology of metabolic acidosis can lead to failure to treat the basic disease process. For example, a child who ingests windshield-wiper fluid containing ethylene glycol may present with severe metabolic acidosis, hypoglycemia, and coma. Failure to be adequately suspicious about this symptom complex would prevent the physician from obtaining immediate treatment (hemodialysis) for this patient. The same holds true for other diseases such as renal failure and shock, which lead to metabolic acidosis.
- If the child requires tracheal intubation secondary to respiratory muscle fatigue or mental status alterations, the practitioners must remember to maintain a high minute ventilation if the metabolic acidosis is still severe when the intervention is performed. Aiming for a PaCO2 expected by the Winter formula is appropriate.
Special Concerns:
- In newborns, frequent administration of hypertonic solutions such as sodium bicarbonate have led to intracranial hemorrhage resulting from hyperosmolality and resultant fluid shifts from the intracellular space.
- Rapid infusion of sodium bicarbonate to correct metabolic acidosis has led to paradoxical CNS acidosis in animal studies. The cause is believed to be sodium bicarbonate dissociating into carbon dioxide and water; carbon dioxide rapidly crosses the blood-brain barrier, but bicarbonate does not, leading to CNS acidosis.
|   |
BIBLIOGRAPHY
| Section 10 of 10 |
|
-
Casaletto JJ: Differential diagnosis of metabolic acidosis. Emerg Med Clin North Am 2005 Aug; 23(3): 771-87, ix[Medline].
-
Fall PJ: A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad Med 2000 Mar; 107(3): 249-50, 253-4, 257-8 passim[Medline].
-
Fattal-Valevski A, Kesler A, Sela BA: Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics 2005 Feb; 115(2): e233-8[Medline].
-
Glaser N, Barnett P, McCaslin I: Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001 Jan 25; 344(4): 264-9[Medline].
-
Levraut J, Grimaud D: Treatment of metabolic acidosis. Curr Opin Crit Care 2003 Aug; 9(4): 260-5[Medline].
-
Naka T, Bellomo R: Bench-to-bedside review: Treating acid-base abnormalities in the intensive care unit - the role of renal replacement therapy. Crit Care 2004 Apr; 8(2): 108-14[Medline].
-
Szaflarski N, Hanson CW: Metabolic acidosis. AACN Clin Issues 1997 Aug; 8(3): 481-96[Medline].
-
Thauvin-Robinet C, Faivre L, Barbier ML: Severe lactic acidosis and acute thiamin deficiency: a report of 11 neonates with unsupplemented total parenteral nutrition. J Inherit Metab Dis 2004; 27(5): 700-4[Medline].
-
Uchida H, Yamamoto H, Kisaki Y, et al: D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004 Apr; 39(4): 634-6[Medline].
Acidosis, Metabolic excerpt |